TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GlaxoSmithKline AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
96,709
|
83,395
|
86,152 |
Financial expenses |
141
|
38
|
29 |
Earnings before taxes |
3,078
|
2,685
|
2,794 |
EBITDA |
3,086
|
2,908
|
3,066 |
Total assets |
30,964
|
31,797
|
36,747 |
Current assets |
30,323
|
31,683
|
36,369 |
Current liabilities |
22,499
|
23,241
|
26,952 |
Equity capital |
8,447
|
8,291
|
9,126 |
- share capital |
4,506
|
4,493
|
4,889 |
Employees (average) |
76
|
70
|
69 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
27.3%
|
26.1%
|
24.8% |
Turnover per employee |
1,272
|
1,191
|
1,249 |
Profit as a percentage of turnover |
3.2%
![]() |
3.2%
![]() |
3.2% |
Return on assets (ROA) |
10.4%
|
8.6%
|
7.7% |
Current ratio |
134.8%
|
136.3%
|
134.9% |
Return on equity (ROE) |
36.4%
|
32.4%
|
30.6% |
Change turnover |
13,071
|
4,221
|
-3,727 |
Change turnover % |
16%
|
5%
|
-4% |
Chg. No. of employees |
6
|
1
|
-4 |
Chg. No. of employees % |
9%
|
1%
|
-5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.